CRISPR-Cas9 Screening in Human Pluripotent Stem Cells

Dr. Ihry of Novartis Neuroscience describes CRISPR-Cas9 Screening in Human Pluripotent Stem Cells for Target Discovery

View the Webinar

Presented by

Covered in this Webinar

How Twist Bioscience deliver highly accurate and uniform oligo pools for CRISPR library generation.

Learn about approaches to reprogram induced pluripotent stem cells (iPSC) using CRISPR-Cas9-based methods.

Learn about the challenges of gene editing and screens in induced pluripotent stem cells.

Dr. Robert Ihry of the Novartis Institutes of Biomedical Research covers methodologies for genome-wide screening with CRISPR-Cas9 in human pluripotent stem cells (hPSCs) and their neuronal progeny.

Share your details to Watch the Webinar

Genes

Oligo Pools

NGS Target Enrichment Solutions

Variant Libraries

Synthetic Controls

Antibody Discovery

CRISPR-Cas9 Screening in Human Pluripotent Stem Cells

Related Resources

Scalable and combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted seq

Drugging the undruggable with protein interference

Multiple Focused CRISPR Libraries from a Single Oligo Pool